European Leukemia Trial Registry
Trial: AMLSG 17-10 (CIARA)

More Details
Title Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML
Scientific Title Phase I/II Study on Cytarabine and Idarubicin Combined With Escalating Doses of Clofarabine as Induction Therapy in Patients With Acute Myeloid Leukemia and High Risk for Induction Failure (AMLSG 17-10)
Short Title AMLSG 17-10 (CIARA)
Trialgroup AMLSG Ulm
Type of Trial multicentric, single-group, open-label
Disease Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status Closed
Start of Recruitment 01.02.2012
Leader Krauter, Prof. Dr. med., Jürgen
Centre of Trial Medizinische Hochschule Hannover (MHH)
Shortprotocol Shortprotocol
created 05.03.2012 Johannes Kraus
changed 03.01.2017 Eva-Maria Ableidinger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org